Previous Article
Infection and Immunity, November 1999, p. 6221-6224, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Differential Expression of Caprine
-Defensins
in Digestive and Respiratory Tissues
Chengquan
Zhao,1
Tung
Nguyen,1
Lide
Liu,1
Olga
Shamova,1,2
Kim
Brogden,3 and
Robert
I.
Lehrer1,4,*
Department of
Medicine1 and Molecular Biology
Institute,4 UCLA School of Medicine, Los
Angeles, California 90095, Institute for Experimental Medicine,
St. Petersburg, Russia,2 and Respiratory
and Neurologic Diseases Research Unit, Midwest Area National Animal
Disease Center, Agricultural Research Service, U.S. Department of
Agriculture, Ames, Iowa 500103
Received 5 April 1999/Returned for modification 28 May
1999/Accepted 6 August 1999
 |
ABSTRACT |
We identified two novel
-defensin precursors, preproGBD-1 and
preproGBD-2, in the tissues of a goat. Although the precursors were
identical in 96.8% of their bases and 88.2% (60 of 68) of their amino
acids, preproGBD-1 was expressed principally in the tongue and
respiratory tract, whereas preproGBD-2 expression predominated throughout the intestine. These findings exemplify the phenomenon of
tissue-specific expression in a family of host defense peptides that
arose before the avian and mammalian lineages diverged.
 |
TEXT |
Defensins are cationic,
antimicrobial peptides with
-sheet structures that are stabilized by
three intramolecular disulfide bonds (15). The
- and
-defensins (BDs) of vertebrates differ with respect to the pairing
of their cysteine residues, but they have similar structures
(31) and originated from shared ancestral genes
(17). Interest in BDs has grown substantially in recent years, spurred by their potential relevance to the pathogenesis of
infection in cystic fibrosis (1, 5, 23). However, our knowledge of their contribution to host defense remains fragmentary and
largely circumstantial. Many BDs are expressed by epithelial cells
(9, 23, 26, 27) and keratinocytes (7)
a
characteristic that distinguishes them from
-defensins. Their
expression in nonmyeloid cells may occur constitutively (21,
30) or in response to signals that are generated during
infection, inflammation, or tissue repair (16, 20, 22, 24).
This report describes two BDs of the goat and demonstrates the highly
tissue-specific expression of these peptides.
Tissue and RNA preparation.
Thirty-nine necropsy tissue
samples were obtained from a healthy male kid goat, by using separate
sterile forceps and scissors for each. Tissues were rinsed in cold
sterile saline, frozen immediately, and stored at
80°C. Total RNA
was purified with the Tri-Reagent RNA isolation procedure (Molecular
Research Center, Cincinnati, Ohio). One hundred microliters of cDNA was
synthesized from 1 µg of each tissue RNA with an Advantage RT-for-PCR
kit (Clontech, Palo Alto, Calif.) and stored frozen until used. Some
limitations of this approach deserve mention. Since our samples came
from a single male goat, they provided no information about the female genitourinary tract or about variations in defensin expression between animals.
Preliminary cDNA cloning.
PCR primer sets based on bovine LAP
and TAP cDNA sequences were used to amplify 5 µl of goat tongue cDNA
for 35 cycles, as follows: 94°C for 20 s, 55°C for 20 s,
and 72°C for 1 min. P1, a sense primer
(5'-CTCCTCTTCCTGGTCCTGT-3'), corresponded to nucleotides 51 to 69 of the bovine LAP cDNA sequence, and P2, an antisense primer (5'-AACTTTGAACAAAATTTATTTATTCT-3'),
corresponded to the region immediately before its poly(A)
tail (22). The reverse transcriptase PCR (RT-PCR) product of
these primers was inserted into the TOPO TA vector (Invitrogen,
Carlsbad, Calif.) and sequenced, revealing a sequence homologous to
both LAP and TAP. To complete the sequence, we performed 5' and 3'
rapid-amplification-of-cDNA-end reactions with a Marathon cDNA kit
(Clontech). A template of purified goat tongue poly(A)+ RNA
was used to synthesize the first-strand cDNA, which served as the
template for second-strand synthesis. The Marathon cDNA adapter was
ligated to the double-stranded cDNA. P3, a gene-specific primer
corresponding to nucleotides 59 to 84 of goat BD-1 (GBD-1) (Fig.
1)
(5'-CCTGTCTGCTGGGTCAGGATTTACTC-3'), and the Marathon adapter
primer were used to get 3'-end GBD-1 cDNA. Gene-specific antisense
primer P4 (5'-CGATCTGTCTAAGGGCGCAGTTTCTG-3'), complementary to nucleotides 249 to 274 of GBD-1 (Fig. 1), and the Marathon adapter
primer were used to obtain the 5' end of GBD-1 cDNA. There was a 216-bp
sequence overlap between the two PCR products. The band was purified
and cloned into a pCRII vector with a TA kit (Invitrogen). Sequencing
was performed by the fluorescein-labeled dideoxynucleotide terminator
method, and sequences were analyzed on an Applied Biosystems 373A DNA
sequencer (Perkin-Elmer, Palo Alto, Calif.). Cloning of GBD-2
is described below.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
cDNA sequences of GBD-1 and GBD-2. The nucleotide and
translated sequences of GBD-1 are shown in full. The nucleotide
sequence of GBD-2 (311 bp) is shown above that of GBD-1 only where the
sequence is different. Amino acids of GBD-2 that differ from those in
GBD-1 are shown below the complete GBD-1 sequence. The putative signal
sequence is underlined. aa, amino acids.
|
|
Tissue expression.
Five microliters of each goat cDNA
preparation was amplified by GBD-specific primers P3 and P4. PCR was
performed with an automated DNA thermal cycler for 25, 30, and 35 cycles as follows: 94°C for 20 s, 60°C for 20 s, and
72°C for 40 s. Two
-actin PCR primers (sense primer P5,
5'-CGTGGCCATCCAGGCTGTGCTGTCC-3', and antisense
primer P6, 5'-GCGATGCCAGGGTACATGGTGGTCC-3') were
designed according to the sheep
-actin cDNA sequence to assess
quality and quantity of goat mRNA (expected PCR product, 530 bp). We
used a master reagent mix to ensure tube-to-tube consistency in cDNA synthesis and PCR. Reaction products were visualized after
electrophoresis in 1.5% agarose gels containing GelStar fluorescent
stain (FMC, Rockland, Maine).
Northern blots.
Total RNA (25 µg) from each tissue was
separated in a 1.0% formaldehyde agarose gel, capillary transferred to
a nylon membrane (GeneScreen Plus; DuPont, Boston, Mass.), and
hybridized with a 32P-labeled cDNA probe (216-bp PCR
product obtained with the P3 and P4 primers). The final membrane wash
prior to autoradiography was done at 65°C with 0.1% sodium dodecyl
sulfate in 0.1× SSC buffer (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate).
Cloning of GBDs.
The full-length cDNA (Fig. 1) reconstructed
from the overlapping 5' and 3' rapid-amplification-of-cDNA-end products
predicts a protein, GBD-1, with 64 amino acid residues, a calculated
mass of 7,258 Da, and a pI of 11.99. GBD-1 contains a typical signal peptide and a propeptide whose C-terminal domain includes six cysteines
with a typical BD motif. GBD-1 cDNA is 95.8% identical to ovine BD
(sheep BD-1), 88.4% identical to bovine LAP, and 71% identical to
porcine lingual pBD-1.
To look for additional GBDs, we subcloned and sequenced a PCR product
obtained by amplifying jejunum cDNA with P7
(5'-GAGCTCGTGACGCCAACATGAGG-3'),
a sequence complementary to
nucleotides 1 to 23 of GBD-1, and
the antisense primer P2. This
identified a second GBD, GBD-2,
whose 311-nucleotide cDNA sequence was
identical to GBD-1 in 301
(96.8%) of its bases (Fig.
1). The
nucleotide differences between
the isoforms would impart eight amino
acid differences, one in
the signal peptide and seven in the propeptide
(Fig.
1).
Tissue expression.
We examined the expression of GBD-1 and -2 in different goat tissues by RT-PCR, with primers that amplified both
peptides. After 25 cycles, GBD transcripts were prominent only in the
tongue, stomach (omasum and abomasum), respiratory tract (turbinates
and trachea), and small intestine (jejunum and ileum). After 35 cycles, the message was readily detected in other respiratory and
gastrointestinal tract tissues but was still not evident in the bone
marrow, spleen, liver, lymph nodes, thymus, or male reproductive tract
(Fig. 2). The female reproductive tract
was not examined. By Northern blotting (Fig.
3), GBD transcripts were detected in the
tongue, stomach, small intestine, nasal turbinates, trachea, and
bronchi.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Tissue expression of GBDs. Expression in various tissues
was examined by RT-PCR. GBD expression after 25, 30, and 35 PCR cycles
is shown, and -actin expression after 35 cycles is shown. The
primers (GBD, P3 and P4; -actin, P5 and P6) are described in the
text. Lanes: M, molecular size markers; 1, bone marrow; 2, mandibular
node; 3, mediastinal node; 4, spleen; 5, thymus; 6, pericardium; 7, tongue; 8, mandibular salivary gland; 9, parotid salivary gland; 10, sublingual salivary gland; 11, tonsils; 12, esophagus; 13, reticulum
stomach; 14, omasum stomach; 15, abomasum stomach; 16, duodenum; 17, jejunum; 18, ileum; 19, proximal colon; 20, medial colon; 21, distal
colon; 22, rectum; 23, anal area; 24, pancreas; 25, liver; 26, gallbladder; 27, renal medulla; 28, renal cortex; 29, bladder-ureter;
30, penis; 31, testis; 32, prostate; 33, epididymis; 34, nasal
turbinate; 35, trachea; 36, bronchus; 37, lung; 38, eye; 39, ileocecal
node.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot analysis. Total RNA prepared from 39 different goat tissues was probed with the 216-bp PCR product amplified
by P3 and P4. The 32P-labeled probe detected both GBD-1 and
GBD-2. See the legend to Fig. 2 for identification of lanes.
|
|
To distinguish GBD-1 from GBD-2, we subcloned and sequenced the RT-PCR
products of P3 and P4 (Fig.
2) from 13 lingual clones,
18 respiratory
tract clones (10 from the trachea and 4 each from
the bronchi and
lung), and 20 digestive tract clones (four each
from the abomasum,
jejunum, ileum, medial colon, and rectum).
All 31 tongue and
respiratory tract clones corresponded to GBD-1,
and all 20 gastrointestinal tract clones corresponded to GBD-2.
To confirm the differential expression of GBD-1 and GBD-2 in
GBD-positive goat tissues by RT-PCR, we designed two defensin-specific
primer sets. P8, a sense primer (5'-ACTCAAGGAATAAGAAGTCG-3')
corresponding
to nucleotides 81 to 100, and P9, an antisense
primer (5'-CATTTTACTGGGGGCCCGAA-3')
complementary to
nucleotides 177 to 196 of the GBD-1 cDNA sequence,
were used to obtain
a 116-bp GBD-1 PCR product. For GBD-2, a sense
primer, P10
(5'-ACTCAAGGAATAATAAATCA-3'), corresponding to nucleotides
81 to 100, and an antisense primer, P11
(5'-CATTTTACTGGGGGCCCGTG-3'),
complementary to nucleotides
177 to 196 of the GBD-2 cDNA sequence,
were
used.
The findings, shown in Fig.
4, confirm
the results of our sequencing studies. Minimal expression of GBD-1 and
-2 took place
in bone marrow, liver, kidney, thymus, spleen, or lymph
nodes.
GBD-1 expression predominated in the tongue, trachea, bronchi,
and lung. GBD-2 expression prevailed throughout the intestinal
tract:
in the stomach, jejunum, ileum, colon, and rectum.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Differential expression of GBD-1 and GBD-2. Differential
expression in selected GBD-expressing goat tissues was examined by
RT-PCR. The specific primers for GBD-1 were P8 and P9 at an annealing
temperature of 58°C. The specific primers for GBD-2 were P10 and P11
at an annealing temperature of 52°C. Additional details are provided
in the text. See the legend to Fig. 2 for identification of lanes.
|
|
Since the GBD-1 and -2 genes undoubtedly arose via duplication of an
ancestral gene also common to sheep BD-1 (see Fig.
6),
their divergent
patterns of expression must reflect different
tissue-specific
regulatory elements. The benefit of selective
expression of GBD-1 and
-2 is not clear. Although the peptides
have almost identical primary
structures, their antimicrobial
properties have not been tested.
Perhaps GBD-1 and -2 differ significantly
in activity against airborne
and food-borne organisms or in their
resistance to other factors (e.g.,
proteases) that are differentially
expressed in the respiratory and
digestive tracts. Peptide level
studies that examine such possibilities
would be of
interest.
Figure
5 shows the sequences of GBD-1 and
-2 and of BDs found in sheep (
11,
12), cattle (
4,
5,
22,
25), pigs
(
29), humans (
2,
7), rhesus
monkeys (
14), rats (
13,
19), mice
(
11), chickens (
3,
8), and turkeys
(
3).
Figure
6 presents a
dendrogram obtained with the Clustal program
(IntelliGenetics) by using
the amino acid sequences shown in Fig.
5. As expected, chicken and
turkey BDs are most closely related
to each other. The early branching
of the avian and mammalian
BDs indicates that both arose from a gene
that existed before
these lineages diverged. The similarity of the
human and rhesus
monkey BD-1 sequences and those of the rat and mouse
implies their
relatively recent divergence from a shared precursor.
Since sheep,
goats, and cattle are all ruminants, it is not surprising
that
all of their BD peptides cluster.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 5.
Sequences of BDs. References for these peptides are as
follows: human BD-1 (2), rhesus monkey BD-1 (14),
rat BD-1 (19), mouse BD-1 (11), mouse BD-2
(18), human BD-2 (7), rat BD-2 (13),
sheep BD-1 (9, 12), sheep BD-2 (9, 11), cow LAP
(22), cow TAP (4), cow EBD (25), cow
BNBD4 (28), pig BD-1 (30), chicken (CHIC) GAL-1
(3), chicken GAL-1A (unpublished data); turkey BD-1
(3), turkey BD-2 (3).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Dendrogram. The prepropeptide sequences shown in Fig. 5
were analyzed by the Clustal program (IntelliGenetics). CHIC,
chicken.
|
|
Nucleotide sequence accession numbers.
The sequences of GBD-1
and GBD-2 were deposited in the EMBL database (accession numbers:
Y17679, GBD-1, and AJ009877, GBD-2).
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the NIH, AI 22839 and AI 40248, and by a Fogarty Award, TW00355.
We thank Gwen Laird and Jean Laufer for their expert technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, Room CHS 37-062, UCLA School of Medicine, 10833 LeConte Ave., Los Angeles, CA 90095-1690. Phone: (310) 825-5340. Fax: (310) 206-8766. E-mail: rlehrer{at}med1.medsch.ucla.edu.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Bals, R.,
X. Wang,
Z. Wu,
T. Freeman,
V. Bafna,
M. Zasloff, and J. M. Wilson.
1998.
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
J. Clin. Investig.
102:874-880[Medline].
|
| 2.
|
Bensch, K. W.,
M. Raida,
H. J. Magert,
P. Schulz-Knappe, and W. G. Forssmann.
1995.
hBD-1: a novel beta-defensin from human plasma.
FEBS Lett.
368:331-335[Medline].
|
| 3.
|
Brockus, C. W.,
M. W. Jackwood, and B. G. Harmon.
1998.
Characterization of beta-defensin prepropeptide mRNA from chicken and turkey bone marrow.
Anim. Genet.
29:283-289[Medline].
|
| 4.
|
Diamond, G.,
M. Zasloff,
H. Eck,
M. Brasseur,
W. L. Maloy, and C. L. Bevins.
1991.
Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.
Proc. Natl. Acad. Sci. USA
88:3952-3956[Abstract/Free Full Text].
|
| 5.
|
Gallagher, D. S., Jr.,
A. M. Ryan,
G. Diamond,
C. T. Bevins, and J. E. Womack.
1995.
Somatic cell mapping of beta-defensin genes to cattle syntenic group U25 and fluorescence in situ localization to chromosome 27.
Mamm. Genome
6:554-556[Medline].
|
| 6.
|
Goldman, M. J.,
G. M. Anderson,
E. D. Stolzenberg,
U. P. Kari,
M. Zasloff, and J. M. Wilson.
1997.
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
Cell
88:553-560[Medline].
|
| 7.
|
Harder, J.,
J. Bartels,
E. Christophers, and J. M. Schroder.
1997.
A peptide antibiotic from human skin.
Nature
387:861[Medline].
|
| 8.
|
Harwig, S. S.,
K. M. Swiderek,
V. N. Kokryakov,
L. Tan,
T. D. Lee,
E. A. Panyutich,
G. M. Aleshina,
O. V. Shamova, and R. I. Lehrer.
1994.
Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.
FEBS Lett.
342:281-285[Medline].
|
| 9.
|
Huttner, K. M., and C. L. Bevins.
1999.
Antimicrobial peptides as mediators of epithelial host defense.
Pediatr. Res.
45:785-794[Medline].
|
| 10.
|
Huttner, K. M.,
D. J. Brezinski-Caliguri,
M. M. Mahoney, and G. Diamond.
1998.
Antimicrobial peptide expression is developmentally regulated in the ovine gastrointestinal tract.
J. Nutr.
128:297S-299S.
|
| 11.
|
Huttner, K. M.,
C. A. Kozak, and C. L. Bevins.
1997.
The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1.
FEBS Lett.
413:45-49[Medline].
|
| 12.
|
Huttner, K. M.,
M. R. Lambeth,
H. R. Burkin,
D. J. Burkin, and T. E. Broad.
1998.
Localization and genomic organization of sheep antimicrobial peptide genes.
Gene
206:85-91[Medline].
|
| 13.
| Jia, H. P., G. S. Wang, K. Wiles, B. F. Tack, and P. B. McCray, Jr. 1998. Rattus
norvegicus beta defensin-2 mRNA, complete cds. GenBank locus
AF068861, accession no. AF0688612. [Online.]
http://www.ncbi.nlm.nih.gov.
|
| 14.
| Kwok, J., G. Hurlock, X. Wu, C. Penland, and J. J. Wine. 14 July 1997, posting date. Macaca mulatta beta
defensin-1 homolog (rhBD-1) mRNA. GenBank locus AF014016, accession no.
AF014016. [Online.] http://www.ncbi.nlm.nih.gov.
|
| 15.
|
Lehrer, R. I., and T. Ganz.
1996.
Endogenous vertebrate antibiotics: defensins, protegrins, and other cysteine-rich antimicrobial peptides.
Ann. N. Y. Acad. Sci.
797:228-239[Medline].
|
| 16.
|
Liu, L.,
L. Wang,
H. P. Jia,
C. Zhao,
H. H. Q. Heng,
B. C. Schutte,
P. B. McCray, Jr., and T. Ganz.
1998.
Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation.
Gene
222:237-244[Medline].
|
| 17.
|
Liu, L.,
C. Zhao,
H. H. Heng, and T. Ganz.
1997.
The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry.
Genomics
43:316-320[Medline].
|
| 18.
|
Morrison, G. M.,
D. J. Davidson, and J. R. A. Dorin.
1999.
A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide.
FEBS Lett.
442:112-116[Medline].
|
| 19.
| Page, R. A., and A. N. Malik. 21 September 1998, posting date. Rattus norvegicus beta
defensin-1 (BD-1) mRNA, complete cds. GenBank locus AF093536, accession
no. AF093536. [Online.] http://www.ncbi.nlm.nih.gov.
|
| 20.
|
Russell, J. P.,
G. Diamond,
A. P. Tarver,
T. F. Scanlin, and C. L. Bevins.
1996.
Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha.
Infect. Immun.
64:1565-1568[Abstract].
|
| 21.
|
Schnapp, D.,
C. J. Reid, and A. Harris.
1998.
Localization of expression of human beta defensin-1 in the pancreas and kidney.
J. Pathol.
186:99-103[Medline].
|
| 22.
|
Schonwetter, B. S.,
E. D. Stolzenberg, and M. A. Zasloff.
1995.
Epithelial antibiotics induced at sites of inflammation.
Science
267:1645-1648[Abstract/Free Full Text].
|
| 23.
|
Singh, P. K.,
H. P. Jia,
K. Wiles,
J. Hesselberth,
L. Liu,
B. A. Conway,
E. P. Greenberg,
E. V. Valore,
M. J. Welsh,
T. Ganz,
B. F. Tack, and P. B. McCray, Jr.
1998.
Production of beta-defensins by human airway epithelia.
Proc. Natl. Acad. Sci. USA
95:14961-14966[Abstract/Free Full Text].
|
| 24.
|
Stolzenberg, E. D.,
G. M. Anderson,
M. R. Ackermann,
R. H. Whitlock, and M. Zasloff.
1997.
Epithelial antibiotic induced in states of disease.
Proc. Natl. Acad. Sci. USA
94:8686-8690[Abstract/Free Full Text].
|
| 25.
|
Tarver, A. P.,
D. P. Clark,
G. Diamond,
J. P. Russell,
H. Erdjument- Bromage,
P. Tempst,
K. S. Cohen,
D. E. Jones,
R. W. Sweeney,
M. Wines,
S. Hwang, and C. L. Bevins.
1998.
Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.
Infect. Immun.
66:1045-1056[Abstract/Free Full Text].
|
| 26.
|
Valore, E. V.,
C. H. Park,
A. J. Quayle,
K. R. Wiles,
P. B. McCray, Jr., and T. Ganz.
1998.
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
J. Clin. Investig.
101:1633-1642[Medline].
|
| 27.
|
Weinberg, A.,
S. Krisanaprakornkit, and B. A. Dale.
1998.
Epithelial antimicrobial peptides: review and significance for oral applications.
Crit. Rev. Oral Biol. Med.
9:399-414[Abstract/Free Full Text].
|
| 28.
| Yount, N. Y., J. Yuan, A. P. Tarver, G. Diamond, J. N. Levy, P. A. Mcguire, C. Mccullough, J. S. Cullor, C. L. Bevins, and M. E. Selsted. 17 July 1997, revision date. Bos taurus neutrophil beta-defensin 4 (BNBD4). GenBank
locus AF008307, accession no. AF008307 U60447 U60446. [Online.]
http: //www.ncbi.nlm.nih.gov.
|
| 29.
|
Zhang, G.,
H. Wu,
J. Shi,
T. Ganz,
C. R. Ross, and F. Blecha.
1998.
Molecular cloning and tissue expression of porcine beta-defensin-1.
FEBS Lett.
424:37-40[Medline].
|
| 30.
|
Zhao, C.,
I. Wang, and R. I. Lehrer.
1996.
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells.
FEBS Lett.
396:319-322[Medline].
|
| 31.
|
Zimmermann, G. R.,
P. Legault,
M. E. Selsted, and A. Pardi.
1995.
Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins.
Biochemistry
34:13663-13671[Medline].
|
Infection and Immunity, November 1999, p. 6221-6224, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cunliffe, R. N., Mahida, Y. R.
(2004). Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol.
75: 49-58
[Abstract]
[Full Text]